Skip to main content
. 2020 Oct 14;21(20):7592. doi: 10.3390/ijms21207592

Table 4.

Overview of c-miRNAs as candidate biomarkers in sporadic non-MEN1 associated tumors.

Biological Fluid Study Population c-miRNAs Platform for miRNA Expression Analysis Reference Genes for qPCR AUC Value ROC Study
Serum Untreated siNET (21), SSA-treated siNET (21), HC (9) miR-96 (↑),
miR-182 (↑),
miR-183 (↑) mIR-196a (↑),
miR-200a (↑),
miR-31 (↓),
miR-129-5p (↓),
miR-133a (↓),
miR-215 (↓),
miR-96 (↓),
miR-182 (↓),
miR-183 (↓),
mIR-196a (↓),
miR-200a (↓)
qPCR miR-16 / [80]
Plasma Localized pancreatic cancer (15), HC (15) miR-196a (↑),
miR-1246 (↑)
qPCR cel-miR-54 / [81]
Serum siNET (32), HC (25) miR-7-5p (↑) qPCR cel-miR-54 0.839 (miR-7-5p) [82]
Serum Pituitary tumor (36), HC (8) miR-16 (↓) qPCR / / [83]
Plasma Different types of PA (45), HC (2) miR-143-3p (↓) NGS, qPCR / 0.79 (miR-143-3p) [84]
Serum GH-PA (6), HC (6) miR-423-5p (↓),
miR-320a (↓)
miRScanTM Panel Chip qPCR QB-spikein-2 / [85]

Enrolled population is shown in parentheses. Table 4 footnotes: siNET = small intestine neuroendocrine tumor; SSA = somatostatin analogue; HC = healthy control; PA = pituitary adenoma; GH-PA = growth hormone-secreting pituitary adenoma.